News

Moderna is due to report its second-quarter financial results on Friday ahead of the market open, a day after announcing ...
Just one day after CEO Stéphane Bancel’s sudden announcement of a 10% workforce reduction, Moderna has released Q2 2025 that ...
Biotech firm aims to streamline operations and reinvest in high-growth areas such as oncology and rare diseases as it targets ...
Shares of Moderna fell sharply Friday after the company lowered the top end of its full-year revenue outlook because of a ...
Moderna reduced its 2025 revenue forecast due to deferred UK vaccine deliveries. Despite a smaller-than-expected quarterly loss, its shares fell 7%. The company faces challenges from declining ...
Moderna Inc. said it will reduce its global workforce by roughly 10% before year’s end, responding to sharply reduced demand ...
Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...
In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...
The biotechnology company on Friday said the U.K. Court of Appeal upheld the validity of its EP'949 patent. It noted that the decision affirms the court's initial ruling from July 2024 that the patent ...